Evolutionary Genomics, Inc.
FNAM
Rank in Stocks
#34912
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the... Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$1.33K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Evolutionary Genomics, Inc. (FNAM)
Category
Healthcare
Operating Margin for Evolutionary Genomics, Inc. (FNAM)
Operating Margin as of November 2026 TTM: 0.00%
According to Evolutionary Genomics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2022 the company had an operating margin of 0.00%.
Operating Margin history for Evolutionary Genomics, Inc. from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -23,038.36% | 3,547.91% |
| 2019 | -631.55% | -13.35% |
| 2018 | -728.83% | -81.71% |
| 2017 | -3,984.79% | 738.14% |
| 2016 | -475.43% | 72.93% |
| 2015 | -274.93% | 3,805.26% |
| 2014 | -7.04% | 286.81% |
| 2013 | -1.82% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Evolutionary Genomics, Inc.'s operating margin
What was Evolutionary Genomics, Inc.'s operating margin in 2022?
In 2022, Evolutionary Genomics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2021.
How has Evolutionary Genomics, Inc.'s operating margin changed since 2017?
From 2017 to 2022, Evolutionary Genomics, Inc.'s operating margin was highest in 2022 (0.00%) and lowest in 2020 (-23,038.36%).
How does Evolutionary Genomics, Inc.'s operating margin compare with similar companies?
Evolutionary Genomics, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.